Duloxetine vs Pembrolizumab

Duloxetine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Duloxetine and Pembrolizumab.

Mechanism of Action

Duloxetine: Serotonin-norepinephrine reuptake inhibitor (SNRI).

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Duloxetine — 12 hours; Pembrolizumab — 26 days.

Chemical Properties

Molecular Formula: Duloxetine — C18H19NOS.

Molecular Weight: Duloxetine — 297.4150 g/mol.

Type: Duloxetine — Small molecule; Pembrolizumab — Antibody.